Global Antimicrobial Nanocoatings Market
As the global economy mends, the 2021 growth of Antimicrobial Nanocoatings will have significant ... Read More
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-Infective Vaccines Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Anti-Infective Vaccines by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Anti-Infective Vaccines by Country/Region, 2017, 2022 & 2028
2.2 Anti-Infective Vaccines Segment by Type
2.2.1 Inactivated Vaccines
2.2.2 Conjugate Vaccines
2.2.3 Live/attenuated Vaccines
2.3 Anti-Infective Vaccines Sales by Type
2.3.1 Global Anti-Infective Vaccines Sales Market Share by Type (2017-2022)
2.3.2 Global Anti-Infective Vaccines Revenue and Market Share by Type (2017-2022)
2.3.3 Global Anti-Infective Vaccines Sale Price by Type (2017-2022)
2.4 Anti-Infective Vaccines Segment by Application
2.4.1 Bacterial Diseases
2.4.2 Viral Diseases
2.5 Anti-Infective Vaccines Sales by Application
2.5.1 Global Anti-Infective Vaccines Sale Market Share by Application (2017-2022)
2.5.2 Global Anti-Infective Vaccines Revenue and Market Share by Application (2017-2022)
2.5.3 Global Anti-Infective Vaccines Sale Price by Application (2017-2022)
3 Global Anti-Infective Vaccines by Company
3.1 Global Anti-Infective Vaccines Breakdown Data by Company
3.1.1 Global Anti-Infective Vaccines Annual Sales by Company (2020-2022)
3.1.2 Global Anti-Infective Vaccines Sales Market Share by Company (2020-2022)
3.2 Global Anti-Infective Vaccines Annual Revenue by Company (2020-2022)
3.2.1 Global Anti-Infective Vaccines Revenue by Company (2020-2022)
3.2.2 Global Anti-Infective Vaccines Revenue Market Share by Company (2020-2022)
3.3 Global Anti-Infective Vaccines Sale Price by Company
3.4 Key Manufacturers Anti-Infective Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Infective Vaccines Product Location Distribution
3.4.2 Players Anti-Infective Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anti-Infective Vaccines by Geographic Region
4.1 World Historic Anti-Infective Vaccines Market Size by Geographic Region (2017-2022)
4.1.1 Global Anti-Infective Vaccines Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Anti-Infective Vaccines Annual Revenue by Geographic Region
4.2 World Historic Anti-Infective Vaccines Market Size by Country/Region (2017-2022)
4.2.1 Global Anti-Infective Vaccines Annual Sales by Country/Region (2017-2022)
4.2.2 Global Anti-Infective Vaccines Annual Revenue by Country/Region
4.3 Americas Anti-Infective Vaccines Sales Growth
4.4 APAC Anti-Infective Vaccines Sales Growth
4.5 Europe Anti-Infective Vaccines Sales Growth
4.6 Middle East & Africa Anti-Infective Vaccines Sales Growth
5 Americas
5.1 Americas Anti-Infective Vaccines Sales by Country
5.1.1 Americas Anti-Infective Vaccines Sales by Country (2017-2022)
5.1.2 Americas Anti-Infective Vaccines Revenue by Country (2017-2022)
5.2 Americas Anti-Infective Vaccines Sales by Type
5.3 Americas Anti-Infective Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Infective Vaccines Sales by Region
6.1.1 APAC Anti-Infective Vaccines Sales by Region (2017-2022)
6.1.2 APAC Anti-Infective Vaccines Revenue by Region (2017-2022)
6.2 APAC Anti-Infective Vaccines Sales by Type
6.3 APAC Anti-Infective Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anti-Infective Vaccines by Country
7.1.1 Europe Anti-Infective Vaccines Sales by Country (2017-2022)
7.1.2 Europe Anti-Infective Vaccines Revenue by Country (2017-2022)
7.2 Europe Anti-Infective Vaccines Sales by Type
7.3 Europe Anti-Infective Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-Infective Vaccines by Country
8.1.1 Middle East & Africa Anti-Infective Vaccines Sales by Country (2017-2022)
8.1.2 Middle East & Africa Anti-Infective Vaccines Revenue by Country (2017-2022)
8.2 Middle East & Africa Anti-Infective Vaccines Sales by Type
8.3 Middle East & Africa Anti-Infective Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Infective Vaccines
10.3 Manufacturing Process Analysis of Anti-Infective Vaccines
10.4 Industry Chain Structure of Anti-Infective Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Infective Vaccines Distributors
11.3 Anti-Infective Vaccines Customer
12 World Forecast Review for Anti-Infective Vaccines by Geographic Region
12.1 Global Anti-Infective Vaccines Market Size Forecast by Region
12.1.1 Global Anti-Infective Vaccines Forecast by Region (2023-2028)
12.1.2 Global Anti-Infective Vaccines Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-Infective Vaccines Forecast by Type
12.7 Global Anti-Infective Vaccines Forecast by Application
13 Key Players Analysis
13.1 Emergent BioDefense Operations Lansing Inc.
13.1.1 Emergent BioDefense Operations Lansing Inc. Company Information
13.1.2 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Offered
13.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Emergent BioDefense Operations Lansing Inc. Main Business Overview
13.1.5 Emergent BioDefense Operations Lansing Inc. Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur Anti-Infective Vaccines Product Offered
13.2.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Merck & Co.
13.3.1 Merck & Co. Company Information
13.3.2 Merck & Co. Anti-Infective Vaccines Product Offered
13.3.3 Merck & Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck & Co. Main Business Overview
13.3.5 Merck & Co. Latest Developments
13.4 MedImmune LLC
13.4.1 MedImmune LLC Company Information
13.4.2 MedImmune LLC Anti-Infective Vaccines Product Offered
13.4.3 MedImmune LLC Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 MedImmune LLC Main Business Overview
13.4.5 MedImmune LLC Latest Developments
13.5 Novartis Vaccines
13.5.1 Novartis Vaccines Company Information
13.5.2 Novartis Vaccines Anti-Infective Vaccines Product Offered
13.5.3 Novartis Vaccines Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Novartis Vaccines Main Business Overview
13.5.5 Novartis Vaccines Latest Developments
13.6 Diagnostics Ltd.
13.6.1 Diagnostics Ltd. Company Information
13.6.2 Diagnostics Ltd. Anti-Infective Vaccines Product Offered
13.6.3 Diagnostics Ltd. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Diagnostics Ltd. Main Business Overview
13.6.5 Diagnostics Ltd. Latest Developments
13.7 Intercell Biomedical
13.7.1 Intercell Biomedical Company Information
13.7.2 Intercell Biomedical Anti-Infective Vaccines Product Offered
13.7.3 Intercell Biomedical Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Intercell Biomedical Main Business Overview
13.7.5 Intercell Biomedical Latest Developments
13.8 MassBiologics
13.8.1 MassBiologics Company Information
13.8.2 MassBiologics Anti-Infective Vaccines Product Offered
13.8.3 MassBiologics Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 MassBiologics Main Business Overview
13.8.5 MassBiologics Latest Developments
13.9 Barr Labs, Inc.
13.9.1 Barr Labs, Inc. Company Information
13.9.2 Barr Labs, Inc. Anti-Infective Vaccines Product Offered
13.9.3 Barr Labs, Inc. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Barr Labs, Inc. Main Business Overview
13.9.5 Barr Labs, Inc. Latest Developments
13.10 Organon Teknika Co.
13.10.1 Organon Teknika Co. Company Information
13.10.2 Organon Teknika Co. Anti-Infective Vaccines Product Offered
13.10.3 Organon Teknika Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Organon Teknika Co. Main Business Overview
13.10.5 Organon Teknika Co. Latest Developments
13.11 GlaxoSmithKline Biologicals
13.11.1 GlaxoSmithKline Biologicals Company Information
13.11.2 GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Offered
13.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 GlaxoSmithKline Biologicals Main Business Overview
13.11.5 GlaxoSmithKline Biologicals Latest Developments
13.12 CSL Ltd.
13.12.1 CSL Ltd. Company Information
13.12.2 CSL Ltd. Anti-Infective Vaccines Product Offered
13.12.3 CSL Ltd. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 CSL Ltd. Main Business Overview
13.12.5 CSL Ltd. Latest Developments
13.13 ID Biomedical Co.
13.13.1 ID Biomedical Co. Company Information
13.13.2 ID Biomedical Co. Anti-Infective Vaccines Product Offered
13.13.3 ID Biomedical Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 ID Biomedical Co. Main Business Overview
13.13.5 ID Biomedical Co. Latest Developments
13.14 Protein Sciences Co.
13.14.1 Protein Sciences Co. Company Information
13.14.2 Protein Sciences Co. Anti-Infective Vaccines Product Offered
13.14.3 Protein Sciences Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Protein Sciences Co. Main Business Overview
13.14.5 Protein Sciences Co. Latest Developments
13.15 Wyeth Pharmaceuticals, Inc.
13.15.1 Wyeth Pharmaceuticals, Inc. Company Information
13.15.2 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Offered
13.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Wyeth Pharmaceuticals, Inc. Main Business Overview
13.15.5 Wyeth Pharmaceuticals, Inc. Latest Developments
13.16 Berna Biotech
13.16.1 Berna Biotech Company Information
13.16.2 Berna Biotech Anti-Infective Vaccines Product Offered
13.16.3 Berna Biotech Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Berna Biotech Main Business Overview
13.16.5 Berna Biotech Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Anti-Infective Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Anti-Infective Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Inactivated Vaccines
Table 4. Major Players of Conjugate Vaccines
Table 5. Major Players of Live/attenuated Vaccines
Table 6. Global Anti-Infective Vaccines Sales by Type (2017-2022) & (Units)
Table 7. Global Anti-Infective Vaccines Sales Market Share by Type (2017-2022)
Table 8. Global Anti-Infective Vaccines Revenue by Type (2017-2022) & ($ million)
Table 9. Global Anti-Infective Vaccines Revenue Market Share by Type (2017-2022)
Table 10. Global Anti-Infective Vaccines Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Anti-Infective Vaccines Sales by Application (2017-2022) & (Units)
Table 12. Global Anti-Infective Vaccines Sales Market Share by Application (2017-2022)
Table 13. Global Anti-Infective Vaccines Revenue by Application (2017-2022)
Table 14. Global Anti-Infective Vaccines Revenue Market Share by Application (2017-2022)
Table 15. Global Anti-Infective Vaccines Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Anti-Infective Vaccines Sales by Company (2020-2022) & (Units)
Table 17. Global Anti-Infective Vaccines Sales Market Share by Company (2020-2022)
Table 18. Global Anti-Infective Vaccines Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Anti-Infective Vaccines Revenue Market Share by Company (2020-2022)
Table 20. Global Anti-Infective Vaccines Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Anti-Infective Vaccines Producing Area Distribution and Sales Area
Table 22. Players Anti-Infective Vaccines Products Offered
Table 23. Anti-Infective Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Anti-Infective Vaccines Sales by Geographic Region (2017-2022) & (Units)
Table 27. Global Anti-Infective Vaccines Sales Market Share Geographic Region (2017-2022)
Table 28. Global Anti-Infective Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Anti-Infective Vaccines Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Anti-Infective Vaccines Sales by Country/Region (2017-2022) & (Units)
Table 31. Global Anti-Infective Vaccines Sales Market Share by Country/Region (2017-2022)
Table 32. Global Anti-Infective Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Anti-Infective Vaccines Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Anti-Infective Vaccines Sales by Country (2017-2022) & (Units)
Table 35. Americas Anti-Infective Vaccines Sales Market Share by Country (2017-2022)
Table 36. Americas Anti-Infective Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Anti-Infective Vaccines Revenue Market Share by Country (2017-2022)
Table 38. Americas Anti-Infective Vaccines Sales by Type (2017-2022) & (Units)
Table 39. Americas Anti-Infective Vaccines Sales Market Share by Type (2017-2022)
Table 40. Americas Anti-Infective Vaccines Sales by Application (2017-2022) & (Units)
Table 41. Americas Anti-Infective Vaccines Sales Market Share by Application (2017-2022)
Table 42. APAC Anti-Infective Vaccines Sales by Region (2017-2022) & (Units)
Table 43. APAC Anti-Infective Vaccines Sales Market Share by Region (2017-2022)
Table 44. APAC Anti-Infective Vaccines Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Anti-Infective Vaccines Revenue Market Share by Region (2017-2022)
Table 46. APAC Anti-Infective Vaccines Sales by Type (2017-2022) & (Units)
Table 47. APAC Anti-Infective Vaccines Sales Market Share by Type (2017-2022)
Table 48. APAC Anti-Infective Vaccines Sales by Application (2017-2022) & (Units)
Table 49. APAC Anti-Infective Vaccines Sales Market Share by Application (2017-2022)
Table 50. Europe Anti-Infective Vaccines Sales by Country (2017-2022) & (Units)
Table 51. Europe Anti-Infective Vaccines Sales Market Share by Country (2017-2022)
Table 52. Europe Anti-Infective Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Anti-Infective Vaccines Revenue Market Share by Country (2017-2022)
Table 54. Europe Anti-Infective Vaccines Sales by Type (2017-2022) & (Units)
Table 55. Europe Anti-Infective Vaccines Sales Market Share by Type (2017-2022)
Table 56. Europe Anti-Infective Vaccines Sales by Application (2017-2022) & (Units)
Table 57. Europe Anti-Infective Vaccines Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Anti-Infective Vaccines Sales by Country (2017-2022) & (Units)
Table 59. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Anti-Infective Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Anti-Infective Vaccines Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Anti-Infective Vaccines Sales by Type (2017-2022) & (Units)
Table 63. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Anti-Infective Vaccines Sales by Application (2017-2022) & (Units)
Table 65. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Anti-Infective Vaccines
Table 67. Key Market Challenges & Risks of Anti-Infective Vaccines
Table 68. Key Industry Trends of Anti-Infective Vaccines
Table 69. Anti-Infective Vaccines Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Anti-Infective Vaccines Distributors List
Table 72. Anti-Infective Vaccines Customer List
Table 73. Global Anti-Infective Vaccines Sales Forecast by Region (2023-2028) & (Units)
Table 74. Global Anti-Infective Vaccines Sales Market Forecast by Region
Table 75. Global Anti-Infective Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Anti-Infective Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Anti-Infective Vaccines Sales Forecast by Country (2023-2028) & (Units)
Table 78. Americas Anti-Infective Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Anti-Infective Vaccines Sales Forecast by Region (2023-2028) & (Units)
Table 80. APAC Anti-Infective Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Anti-Infective Vaccines Sales Forecast by Country (2023-2028) & (Units)
Table 82. Europe Anti-Infective Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Anti-Infective Vaccines Sales Forecast by Country (2023-2028) & (Units)
Table 84. Middle East & Africa Anti-Infective Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Anti-Infective Vaccines Sales Forecast by Type (2023-2028) & (Units)
Table 86. Global Anti-Infective Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Anti-Infective Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Anti-Infective Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Anti-Infective Vaccines Sales Forecast by Application (2023-2028) & (Units)
Table 90. Global Anti-Infective Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Anti-Infective Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Anti-Infective Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 93. Emergent BioDefense Operations Lansing Inc. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Offered
Table 95. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Emergent BioDefense Operations Lansing Inc. Main Business
Table 97. Emergent BioDefense Operations Lansing Inc. Latest Developments
Table 98. Sanofi Pasteur Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Pasteur Anti-Infective Vaccines Product Offered
Table 100. Sanofi Pasteur Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Sanofi Pasteur Main Business
Table 102. Sanofi Pasteur Latest Developments
Table 103. Merck & Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Merck & Co. Anti-Infective Vaccines Product Offered
Table 105. Merck & Co. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Merck & Co. Main Business
Table 107. Merck & Co. Latest Developments
Table 108. MedImmune LLC Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. MedImmune LLC Anti-Infective Vaccines Product Offered
Table 110. MedImmune LLC Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. MedImmune LLC Main Business
Table 112. MedImmune LLC Latest Developments
Table 113. Novartis Vaccines Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Novartis Vaccines Anti-Infective Vaccines Product Offered
Table 115. Novartis Vaccines Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Novartis Vaccines Main Business
Table 117. Novartis Vaccines Latest Developments
Table 118. Diagnostics Ltd. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Diagnostics Ltd. Anti-Infective Vaccines Product Offered
Table 120. Diagnostics Ltd. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Diagnostics Ltd. Main Business
Table 122. Diagnostics Ltd. Latest Developments
Table 123. Intercell Biomedical Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Intercell Biomedical Anti-Infective Vaccines Product Offered
Table 125. Intercell Biomedical Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Intercell Biomedical Main Business
Table 127. Intercell Biomedical Latest Developments
Table 128. MassBiologics Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. MassBiologics Anti-Infective Vaccines Product Offered
Table 130. MassBiologics Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. MassBiologics Main Business
Table 132. MassBiologics Latest Developments
Table 133. Barr Labs, Inc. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Barr Labs, Inc. Anti-Infective Vaccines Product Offered
Table 135. Barr Labs, Inc. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Barr Labs, Inc. Main Business
Table 137. Barr Labs, Inc. Latest Developments
Table 138. Organon Teknika Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. Organon Teknika Co. Anti-Infective Vaccines Product Offered
Table 140. Organon Teknika Co. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Organon Teknika Co. Main Business
Table 142. Organon Teknika Co. Latest Developments
Table 143. GlaxoSmithKline Biologicals Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Offered
Table 145. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. GlaxoSmithKline Biologicals Main Business
Table 147. GlaxoSmithKline Biologicals Latest Developments
Table 148. CSL Ltd. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. CSL Ltd. Anti-Infective Vaccines Product Offered
Table 150. CSL Ltd. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. CSL Ltd. Main Business
Table 152. CSL Ltd. Latest Developments
Table 153. ID Biomedical Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. ID Biomedical Co. Anti-Infective Vaccines Product Offered
Table 155. ID Biomedical Co. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. ID Biomedical Co. Main Business
Table 157. ID Biomedical Co. Latest Developments
Table 158. Protein Sciences Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. Protein Sciences Co. Anti-Infective Vaccines Product Offered
Table 160. Protein Sciences Co. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. Protein Sciences Co. Main Business
Table 162. Protein Sciences Co. Latest Developments
Table 163. Wyeth Pharmaceuticals, Inc. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 164. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Offered
Table 165. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 166. Wyeth Pharmaceuticals, Inc. Main Business
Table 167. Wyeth Pharmaceuticals, Inc. Latest Developments
Table 168. Berna Biotech Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 169. Berna Biotech Anti-Infective Vaccines Product Offered
Table 170. Berna Biotech Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 171. Berna Biotech Main Business
Table 172. Berna Biotech Latest Developments
List of Figures
Figure 1. Picture of Anti-Infective Vaccines
Figure 2. Anti-Infective Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Infective Vaccines Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Anti-Infective Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Anti-Infective Vaccines Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Inactivated Vaccines
Figure 10. Product Picture of Conjugate Vaccines
Figure 11. Product Picture of Live/attenuated Vaccines
Figure 12. Global Anti-Infective Vaccines Sales Market Share by Type in 2021
Figure 13. Global Anti-Infective Vaccines Revenue Market Share by Type (2017-2022)
Figure 14. Anti-Infective Vaccines Consumed in Bacterial Diseases
Figure 15. Global Anti-Infective Vaccines Market: Bacterial Diseases (2017-2022) & (Units)
Figure 16. Anti-Infective Vaccines Consumed in Viral Diseases
Figure 17. Global Anti-Infective Vaccines Market: Viral Diseases (2017-2022) & (Units)
Figure 18. Global Anti-Infective Vaccines Sales Market Share by Application (2017-2022)
Figure 19. Global Anti-Infective Vaccines Revenue Market Share by Application in 2021
Figure 20. Anti-Infective Vaccines Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Anti-Infective Vaccines Revenue Market Share by Company in 2021
Figure 22. Global Anti-Infective Vaccines Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Anti-Infective Vaccines Revenue Market Share by Geographic Region in 2021
Figure 24. Global Anti-Infective Vaccines Sales Market Share by Region (2017-2022)
Figure 25. Global Anti-Infective Vaccines Revenue Market Share by Country/Region in 2021
Figure 26. Americas Anti-Infective Vaccines Sales 2017-2022 (Units)
Figure 27. Americas Anti-Infective Vaccines Revenue 2017-2022 ($ Millions)
Figure 28. APAC Anti-Infective Vaccines Sales 2017-2022 (Units)
Figure 29. APAC Anti-Infective Vaccines Revenue 2017-2022 ($ Millions)
Figure 30. Europe Anti-Infective Vaccines Sales 2017-2022 (Units)
Figure 31. Europe Anti-Infective Vaccines Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Anti-Infective Vaccines Sales 2017-2022 (Units)
Figure 33. Middle East & Africa Anti-Infective Vaccines Revenue 2017-2022 ($ Millions)
Figure 34. Americas Anti-Infective Vaccines Sales Market Share by Country in 2021
Figure 35. Americas Anti-Infective Vaccines Revenue Market Share by Country in 2021
Figure 36. United States Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Anti-Infective Vaccines Sales Market Share by Region in 2021
Figure 41. APAC Anti-Infective Vaccines Revenue Market Share by Regions in 2021
Figure 42. China Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Anti-Infective Vaccines Sales Market Share by Country in 2021
Figure 49. Europe Anti-Infective Vaccines Revenue Market Share by Country in 2021
Figure 50. Germany Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Anti-Infective Vaccines Revenue Market Share by Country in 2021
Figure 57. Egypt Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Anti-Infective Vaccines in 2021
Figure 63. Manufacturing Process Analysis of Anti-Infective Vaccines
Figure 64. Industry Chain Structure of Anti-Infective Vaccines
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
As the global economy mends, the 2021 growth of Antimicrobial Nanocoatings will have significant ... Read More
As the global economy mends, the 2021 growth of Antioxidant BHT will have significant change from ... Read More
As the global economy mends, the 2021 growth of Anti-Reflective Glass Coatings will have signific ... Read More
As the global economy mends, the 2021 growth of Antisense and RNAi Therapeutics will have signifi ... Read More